Effects of pioglitazone on lipid and lipoprotein metabolism.
about
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineAcute Effect of Metformin on Postprandial Hypertriglyceridemia through Delayed Gastric EmptyingIs the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisGlitazones for human nonalcoholic steatohepatitisThe effects of pioglitazone on biochemical markers of bone turnover in the patients with type 2 diabetes.Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease.Thiazolidinediones as therapy for endometriosis: a case series.Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.Lipid effects of endocrine medications.The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Pharmacological agents for NASH.Intestinal nuclear receptors in HDL cholesterol metabolism.Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease.The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.Pharmacologic Treatment of Dyslipidemia in Diabetes: A Case for Therapies in Addition to Statins.Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study.Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.Pathophysiology of Diabetic DyslipidemiaThiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin
P2860
Q24608464-D876B2C0-9957-4BA9-8238-0492E9D32EBCQ33839003-D2D60321-F49C-447A-8B4F-C5A9569867F0Q33880174-D1C5757B-9097-4F0A-955C-4F2E69EE794DQ35191067-F1901983-E123-43DB-A372-3311FE061CFEQ36969616-E25EB732-6F8E-48CD-81E3-52943C141ADBQ37266575-1EBD16CD-A0BC-4296-8381-756ECF183ED3Q37466788-75C55442-3977-4DB7-BFD4-AAF2DA81FB61Q37577162-53856074-2F34-4143-A77C-AAA668CA38E5Q37811982-92072B5E-9035-49DA-83BF-48AA978A1053Q38102596-ACB21513-DD48-46F8-BE1E-C31451D7FAF0Q38152646-A58E0257-08EF-4BFA-9608-05CF59B22805Q38234847-31550166-74E0-40BC-B0A0-485B27CDE57AQ38921141-69CE4442-16E0-4FDF-8A5B-8ACB2053F80AQ38974109-A5EFC3BB-35DD-408B-AC44-125A3E77ACABQ39320400-5F6285EC-2866-4790-BAC5-0DDFF8BBA37EQ41258262-B8087A71-631C-4FF0-93F4-AF62AEAB3449Q46024732-3A74D78F-4524-49AB-917E-9FF67DD973C4Q58774678-40EF39CD-91CE-4B23-A206-356EAED8BA8AQ58802792-2D565745-DBE3-4BB9-B29B-197C42F8C0C7
P2860
Effects of pioglitazone on lipid and lipoprotein metabolism.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects of pioglitazone on lipid and lipoprotein metabolism.
@en
type
label
Effects of pioglitazone on lipid and lipoprotein metabolism.
@en
prefLabel
Effects of pioglitazone on lipid and lipoprotein metabolism.
@en
P2860
P1476
Effects of pioglitazone on lipid and lipoprotein metabolism.
@en
P2093
D John Betteridge
P2860
P304
P356
10.1111/J.1463-1326.2007.00715.X
P577
2007-09-01T00:00:00Z